A subscription to JoVE is required to view this content.
-- views • 1:47 min
Caspase-3 and caspase-7 are proteases that recognize the DEVD tetrapeptide sequence in target proteins, cleaving them at the C-terminus of the aspartic acid residue. These play a prominent role in the apoptosis - programmed cell death - cascade.
To assess caspase-3/7 activity in apoptotic cells, begin with a tube containing a frog toe skin explant infected with apoptosis-inducing fungi. Add a suitable buffer to the tube and a few metallic beads.
Use bead-beating to disrupt the skin cells and release cellular contents, including caspase-3/7 proteins. Centrifuge the tube, pelleting cell debris, and organelles. Aspirate the protein-rich supernatant from the tube and pipette into the wells of a multiwell assay plate.
Supplement the wells with the luminogenic caspase reagent. This reagent consists of a proluminescent substrate containing the DEVD peptide in a buffered solution containing ATP, magnesium ions, and luciferase enzyme.
Mix the contents of the well and incubate. During incubation, caspase-3/7 cleaves the proluminescent substrate, releasing aminoluciferin - a substrate for luciferase - into the solution.
In the presence of ATP and magnesium ions, luciferase oxidizes the released aminoluciferin, generating a bioluminescent product. The amount of light produced during the reaction is proportional to the caspase activity.
Related Videos
64 Views
Related Videos
15.9K Views
Related Videos
15.3K Views
Related Videos
19.8K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved